A panel of a mitogenic (PDGF), biochemical (albumin) and demographic (age) parameters for the non-invasive assessment of hepatic fibrosis

References

• Almpanis Z, Demonakou M, Tiniakos D. Evaluation of liver fibrosis: “something old, something new…”. Ann Gastroenterol. 2016;29:445.
   PubMed Web of Science ®Google Scholar
• Wang HW, Peng CY, Lai HC, et al. New noninvasive index for predicting liver fibrosis in Asian patients with chronic viral hepatitis. Sci Rep. 2017;7:3259.
   PubMed Web of Science ®Google Scholar
• Chou R, Wasson N. Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection: a systematic review. Ann Intern Med. 2013;158:807–820.
   PubMed Web of Science ®Google Scholar
• Lambrecht J, Verhulst S, Mannaerts I, et al. Prospects in non-invasive assessment of liver fibrosis: liquid biopsy as the future gold standard? Biochim Biophys Acta. 2018;1864:1024–1036.
   PubMed Web of Science ®Google Scholar
• Attallah AM, Omran D, Omran MM, et al. Extracellular matrix proteins substantiate IL-28B T allele effect on histological outcome of chronic hepatitis C. Ann Hepatol. 2018;17:569–576.
   PubMed Web of Science ®Google Scholar
• Omran D, Zayed RA, Nabeel MM, et al. Evaluating diagnostic accuracy of noninvasive tests in assessment of significant liver fibrosis in chronic hepatitis C Egyptian patients. Viral Immunol. 2018;31:315–320.
   PubMed Web of Science ®Google Scholar
• Omran D, Yosry A, Darweesh SK, et al. Enhanced liver fibrosis test using ELISA assay accurately discriminates advanced stage of liver fibrosis as determined by transient elastography fibroscan in treatment naïve chronic HCV patients. Clin Exp Med. 2018;18:45–50.
   PubMed Web of Science ®Google Scholar
• Attallah AM, Omran MM, Farid K, et al. Development of a novel score for liver fibrosis staging and comparison with eight simple laboratory scores in large numbers of HCV-monoinfected patients. Clin Chim Acta. 2012;413:1725–1730.
   PubMed Web of Science ®Google Scholar
• Attallah AM, El-Far M, Abdel Malak CA, et al. Fibro-check: a combination of direct and indirect markers for liver fibrosis staging in chronic hepatitis C patients. Ann Hepatol. 2015;14:225–233.
   PubMed Web of Science ®Google Scholar
• Attallah AM, El‐Far M, Omran MM, et al. Noninvasive diagnosis of liver fibrosis and cirrhosis in chronic hepatitis C patients. J Clin Lab Anal. 2013;27:121–129.
   PubMed Web of Science ®Google Scholar
• Attallah A, Omran D, Omran M, et al. Fibro-Mark: a panel of laboratory parameters for predicting significant fibrosis in chronic hepatitis C patients. Br J Biomed Sci. 2018;75:19–23.
   PubMed Web of Science ®Google Scholar
• Fouad SA, Esmat S, Omran D, et al. Noninvasive assessment of hepatic fibrosis in Egyptian patients with chronic hepatitis C virus infection. World J Gastroenterol. 2012;18:2988.
   PubMed Web of Science ®Google Scholar
• Gressner O, Weiskirchen R, Gressner A. Biomarkers of hepatic fibrosis, fibrogenesis and genetic pre‐disposition pending between fiction and reality. J Cell Mol Med. 2007;11:1031–1051.
   PubMed Web of Science ®Google Scholar
• Nallagangula KS, Nagaraj SK, Venkataswamy L, et al. Liver fibrosis: a compilation on the biomarkers status and their significance during disease progression. Future Sci OA. 2018;4:FSO250.
   PubMed Web of Science ®Google Scholar
• Borkham-Kamphorst E, Weiskirchen R. The PDGF system and its antagonists in liver fibrosis. Cytokine Growth Factor Rev. 2016;28:53–61.
   PubMed Web of Science ®Google Scholar
• Hernandez-Gea V, Friedman SL. Pathogenesis of liver fibrosis. Annu Rev Pathol. 2011;6:425–456.
   PubMed Web of Science ®Google Scholar
• Pinzani M, Milani S, Herbst H, et al. Expression of platelet-derived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis. Am J Pathol. 1996;148:785–800.
   PubMed Web of Science ®Google Scholar
• Ikura Y, Morimoto H, Ogami M, et al. Expression of platelet-derived growth factor and its receptor in livers of patients with chronic liver disease. J Gastroenterol. 1997;32:496–501.
   PubMed Web of Science ®Google Scholar
• Sandrin L, Fourquet B, Hasquenoph JM, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003;29:1705–1713.
   PubMed Web of Science ®Google Scholar
• Medhat E, Salama H, Fouad H, et al. Serum soluble CD14 in Egyptian patients with chronic hepatitis C: its relationship to disease progression and response to treatment. J Interferon Cytokine Res. 2015;35:563–568.
   PubMed Web of Science ®Google Scholar
• Mobarak L, Nabeel MM, Hassan E, et al. Real-time elastography as a noninvasive assessment of liver fibrosis in chronic hepatitis C Egyptian patients: a prospective study. Ann Gastroenterol. 2016;29:358.
   PubMed Web of Science ®Google Scholar
• Zayed RA, Omran D, Mokhtar DA, et al. Association of toll-like receptor 3 and toll-like receptor 9 single nucleotide polymorphisms with hepatitis C virus infection and hepatic fibrosis in egyptian patients. Am J Trop Med Hyg. 2017;96:720–726.
   PubMed Web of Science ®Google Scholar
• Jiao J, Friedman SL, Aloman C. Hepatic fibrosis. Curr Opin Gastroenterol. 2009;25:223–229.
   PubMed Web of Science ®Google Scholar
• Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005;115:209–218.
   PubMed Web of Science ®Google Scholar
• Arthur MJ, Mann DA, Iredale JP. Tissue inhibitors of metalloproteinases, hepatic stellate cells and liver fibrosis. J Gastroenterol Hepatol. 1998;13:S33–S38.
   PubMed Web of Science ®Google Scholar
• Farrugia A. Albumin usage in clinical medicine: tradition or therapeutic? Transfus Med Rev. 2010;24:53–63.
   PubMed Web of Science ®Google Scholar
• Evans T. albumin as a drug—biological effects of albumin unrelated to oncotic pressure. Aliment Pharmacol Ther. 2002;16:6–11.
   PubMed Web of Science ®Google Scholar
• Nicholson J, Wolmarans M, Park G. The role of albumin in critical illness. Br J Anaesth. 2000;85:599–610.
   PubMed Web of Science ®Google Scholar
• Plebani M, Basso D. Non-invasive assessment of chronic liver and gastric diseases. Clin Chim Acta. 2007;381:39–49.
   PubMed Web of Science ®Google Scholar
• Lui F. Laboratory tests in hepatic failure. Anaesth Intensive Care Med. 2012;13:46–47.
   Google Scholar
• Forns X, Ampurdanes S, Llovet JM, et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatol. 2002;36:986–992.
   PubMed Web of Science ®Google Scholar
• Vallet‐Pichard A, Mallet V, Nalpas B, et al. FIB‐4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatol. 2007;46:32–36.
   PubMed Web of Science ®Google Scholar
• Hsieh Y-Y, Tung S-Y, Lee I-L, et al. FibroQ: an easy and useful noninvasive test for predicting liver fibrosis in patients with chronic viral hepatitis. Chang Gung Med J. 2009;32:614–622.
   PubMedGoogle Scholar
• Ahmad W, Ijaz B, Javed FT, et al. A comparison of four fibrosis indexes in chronic HCV: development of new fibrosis-cirrhosis index (FCI). BMC Gastroenterol. 2011;11:44.
   PubMed Web of Science ®Google Scholar
• Lackner C, Struber G, Liegl B, et al. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C. Hepatol. 2005;41:1376–1382.
   PubMed Web of Science ®Google Scholar
• Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatol. 2003;38:518–526.
   PubMed Web of Science ®Google Scholar
• Sebastiani G, Alberti A. Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy. World J Gastroenterol. 2006;12:3682.
   PubMed Web of Science ®Google Scholar
• Sebastiani G, Vario A, Guido M, et al. Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C. J hepatol. 2006;44:686–693.
   PubMed Web of Science ®Google Scholar